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background:  In clinical trials that compare different treatment strategies in patients with acute coronary syndrome (ACS), elderly patients are 
poorly represented. Aim of this study was to investigate the cost/benefit ratio of invasive versus conservative therapy in ACS octogenarian patients.
materials and methods: From April 2009 to November 2012, 331 (26%) aged ≥ 80 years were admitted to our CCU diagnosed with ACS. 109 
patients (32.9 %) were admitted for an ST elevation myocardial infarction (STEMI) and 222 (66.8 %) for non-ST elevation myocardial infarction 
(NSTEMI). Patients were followed-up (FU) for 17.6 ± 12.8 months and we evaluated the cardiovascular death.
results: Mean age of our study population was 84.9 ± 4 yrs, 166 (50.2 %) were male. On admission, patients had a mean GRACE score of 190.5 
± 32.9 and a CRUSADE score of 51.2 ± 12. During hospitalization 218 (65.9 %, group 1) patients underwent coronary angiography within 12 hrs 
after the onset of symptoms in STEMI and within 72 hours in NSTEMI and 113 (34.1%, group 2) a conservative therapy. Group 1 were younger (84,0 
± 3,4 vs 86,5 ± 4,7; p=0,001) and had both a lower GRACE Score (186,0 ± 32,2 vs 198,7 ± 32,7; p=0,001) and CRUSADE Score (48,4 ± 11,1 
vs 58,4 ± 11,1; p=0,0001) with a better LVF (EF 48,2 ± 13,3 vs 44,3 ± 13,5 ; p=0,016) on admission. During hospitalization 57 pts died and 37 
were lost to FU. At discharge, group 1 was prescribed more thienopyridines (95% vs 77%, p=0.0001), beta- blockers (80% vs 56.9%, p=0.0001) and 
statins (93.3% vs 64.2%) than group 2. During FU there were 81 deaths with a mortality rate of 34.1%. Kaplan-Meier analysis showed a significantly 
lower survival curve in Group 2 patients (42.3%) than group 1 (77.4%, log rank p= 0.0001, chi-square 31.3). In multivariate analysis independent 
predictor of mortality at FU was a conservative approach (OR 2.5, CI 1.19 to 5.1, p = 0.015) and a low glomerular filtration rate (OR 7.1, CI 1.0-1.1, 
p = 0.0001).
Conclusions: In elderly patients with ACS and high risk profile, invasive strategy combined with a more aggressive medical therapy appear a better 
strategy to improve outcome at FU
